89 related articles for article (PubMed ID: 24056727)
1. The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy.
Malaney P; Uversky VN; Davé V
Mol Biosyst; 2013 Nov; 9(11):2877-88. PubMed ID: 24056727
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic disorder in PTEN and its interactome confers structural plasticity and functional versatility.
Malaney P; Pathak RR; Xue B; Uversky VN; Davé V
Sci Rep; 2013; 3():2035. PubMed ID: 23783762
[TBL] [Abstract][Full Text] [Related]
3. Identification of intrinsically disordered regions in PTEN and delineation of its function via a network approach.
Malaney P; Uversky VN; Davé V
Methods; 2015 May; 77-78():69-74. PubMed ID: 25449897
[TBL] [Abstract][Full Text] [Related]
4. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
[TBL] [Abstract][Full Text] [Related]
5. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).
Hafsi S; Pezzino FM; Candido S; Ligresti G; Spandidos DA; Soua Z; McCubrey JA; Travali S; Libra M
Int J Oncol; 2012 Mar; 40(3):639-44. PubMed ID: 22200790
[TBL] [Abstract][Full Text] [Related]
6. The PTEN Tumor Suppressor Forms Homodimers in Solution.
Heinrich F; Chakravarthy S; Nanda H; Papa A; Pandolfi PP; Ross AH; Harishchandra RK; Gericke A; Lösche M
Structure; 2015 Oct; 23(10):1952-1957. PubMed ID: 26299948
[TBL] [Abstract][Full Text] [Related]
7. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
[TBL] [Abstract][Full Text] [Related]
8. Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation.
Chen Z; Dempsey DR; Thomas SN; Hayward D; Bolduc DM; Cole PA
J Biol Chem; 2016 Jul; 291(27):14160-14169. PubMed ID: 27226612
[TBL] [Abstract][Full Text] [Related]
9. Tenets of PTEN tumor suppression.
Salmena L; Carracedo A; Pandolfi PP
Cell; 2008 May; 133(3):403-14. PubMed ID: 18455982
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.
McCubrey JA; Steelman LS; Kempf CR; Chappell WH; Abrams SL; Stivala F; Malaponte G; Nicoletti F; Libra M; Bäsecke J; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Cocco L; Martelli AM
J Cell Physiol; 2011 Nov; 226(11):2762-81. PubMed ID: 21302297
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
Kaper F; Dornhoefer N; Giaccia AJ
Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
[TBL] [Abstract][Full Text] [Related]
13. Post-translational modifications of PTEN and their potential therapeutic implications.
Singh G; Chan AM
Curr Cancer Drug Targets; 2011 Jun; 11(5):536-47. PubMed ID: 21486223
[TBL] [Abstract][Full Text] [Related]
14. In Cell and In Vitro Assays to Measure PTEN Ubiquitination.
Gupta A; Maccario H; Kriplani N; Leslie NR
Methods Mol Biol; 2016; 1388():155-65. PubMed ID: 27033076
[TBL] [Abstract][Full Text] [Related]
15. Opening the conformation is a master switch for the dual localization and phosphatase activity of PTEN.
Nguyen HN; Yang JM; Miyamoto T; Itoh K; Rho E; Zhang Q; Inoue T; Devreotes PN; Sesaki H; Iijima M
Sci Rep; 2015 Jul; 5():12600. PubMed ID: 26216063
[TBL] [Abstract][Full Text] [Related]
16. Interactomic affinity profiling by holdup assay: Acetylation and distal residues impact the PDZome-binding specificity of PTEN phosphatase.
Jané P; Gógl G; Kostmann C; Bich G; Girault V; Caillet-Saguy C; Eberling P; Vincentelli R; Wolff N; Travé G; Nominé Y
PLoS One; 2020; 15(12):e0244613. PubMed ID: 33382810
[TBL] [Abstract][Full Text] [Related]
17. The intrinsically disordered tails of PTEN and PTEN-L have distinct roles in regulating substrate specificity and membrane activity.
Masson GR; Perisic O; Burke JE; Williams RL
Biochem J; 2016 Jan; 473(2):135-44. PubMed ID: 26527737
[TBL] [Abstract][Full Text] [Related]
18. Rapid Detection of Dynamic PTEN Regulation in Living Cells Using Intramolecular BRET.
Misticone S; Lima-Fernandes E; Scott MG
Methods Mol Biol; 2016; 1388():95-110. PubMed ID: 27033073
[TBL] [Abstract][Full Text] [Related]
19. PTEN proteoforms in biology and disease.
Malaney P; Uversky VN; Davé V
Cell Mol Life Sci; 2017 Aug; 74(15):2783-2794. PubMed ID: 28289760
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive in silico mutational-sensitivity analysis of PTEN establishes signature regions implicated in pathogenesis of Autism Spectrum Disorders.
S Niranjana Murthy A; V Suresh R; Nallur B R
Genomics; 2021 Jan; 113(1 Pt 2):999-1017. PubMed ID: 33152507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
